The Pharmacokinetics of D565 and the Drug Effect of D565 on Pharmacokinetic Characteristics of D930

Phase 1 Completed 15 enrolled Chong Kun Dang Pharmaceutical

NaSingle-groupOpen-labelTreatment

Summary

This study is a single sequence, 3-period, multiple-dose study to evaluate the pharmacokinetics of D565 and the drug effect of D565 on pharmacokinetic characteristics of D930 in healthy male volunteers.

Timeline

Start: 2017-02-17
Primary completion: 2017-03-17
Completion: 2017-03-20

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	D565	Unknown	—	—
Subject	D930	Unknown	—	—

Indications

No indication recorded.